Marta Doménech

804 total citations
31 papers, 410 citations indexed

About

Marta Doménech is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Marta Doménech has authored 31 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Genetics. Recurrent topics in Marta Doménech's work include Glioma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (7 papers). Marta Doménech is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (7 papers). Marta Doménech collaborates with scholars based in Spain, Poland and Greece. Marta Doménech's co-authors include Ainhoa Hernández, Carmen Balañá, Andrea Plaja, Eva Martinez‐Balibrea, Cristina Carrato, Teresa Morán, María Ochoa de Olza, Ramón Salazar, Marta Gil-Martín and Manel Cascalló and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Marta Doménech

28 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Doménech Spain	11	165	140	127	113	77	31	410
Jonathan Lerner United States	6	162 1.0×	110 0.8×	50 0.4×	138 1.2×	129 1.7×	7	441
Justin Wang United States	9	206 1.2×	144 1.0×	87 0.7×	41 0.4×	26 0.3×	12	430
Simon Khagi United States	9	101 0.6×	113 0.8×	45 0.4×	110 1.0×	35 0.5×	28	325
Mariza Daras United States	13	168 1.0×	175 1.3×	37 0.3×	153 1.4×	32 0.4×	38	479
Vidya Bodempudi United States	13	212 1.3×	94 0.7×	79 0.6×	45 0.4×	46 0.6×	14	466
Michaël H. Meel Netherlands	13	172 1.0×	68 0.5×	65 0.5×	153 1.4×	23 0.3×	20	367
Marni B. Siegel United States	11	182 1.1×	160 1.1×	156 1.2×	32 0.3×	61 0.8×	16	410
Anxo Martínez-Ordóñez Spain	10	180 1.1×	193 1.4×	144 1.1×	34 0.3×	21 0.3×	15	434
Philippe De La Rochère France	6	149 0.9×	206 1.5×	77 0.6×	47 0.4×	31 0.4×	7	478
Joo Hyoung Lee United States	11	177 1.1×	173 1.2×	100 0.8×	32 0.3×	33 0.4×	27	468

Countries citing papers authored by Marta Doménech

Since Specialization

Citations

This map shows the geographic impact of Marta Doménech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Doménech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Doménech more than expected).

Fields of papers citing papers by Marta Doménech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Doménech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Doménech. The network helps show where Marta Doménech may publish in the future.

Co-authorship network of co-authors of Marta Doménech

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Doménech. A scholar is included among the top collaborators of Marta Doménech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Doménech. Marta Doménech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muñoz‐Mármol, Ana M, Bárbara Meléndez, Ainhoa Hernández, et al.. (2025). Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib. Cancers. 17(3). 375–375. 2 indexed citations

Pineda, Estela, Ainhoa Hernández, Marta Doménech, et al.. (2024). The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers. 16(4). 735–735. 1 indexed citations

Rodríguez‐Vida, Alejo, Begoña P. Valderrama, Daniel Castellano, et al.. (2024). Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study. ESMO Open. 9(9). 103690–103690.

Carcereny, Enric, Maria Saigí, Anna Esteve, et al.. (2023). P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 18(11). S235–S235. 1 indexed citations

Cucurull, Marc, Carolina Sanz, Enric Carcereny, et al.. (2023). Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C. Frontiers in Oncology. 13. 1239000–1239000. 2 indexed citations

Pineda, Estela, et al.. (2023). Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects. OncoTargets and Therapy. Volume 16. 71–86. 20 indexed citations

Hernández, Ainhoa, Ana M Muñoz‐Mármol, Anna Esteve‐Codina, et al.. (2022). In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma. Scientific Reports. 12(1). 14439–14439. 2 indexed citations

Balañá, Carmen, Sara Castañer, Cristina Carrato, et al.. (2022). Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics. Frontiers in Neurology. 13. 865171–865171. 18 indexed citations

Saigí, Maria, Enric Carcereny, Teresa Morán, et al.. (2022). Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer. Cancer Treatment Reviews. 109. 102430–102430. 6 indexed citations

10.

Quirant‐Sánchez, Bibiana, Eudald Felip, Maria Saigí, et al.. (2022). OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort. Journal of Thoracic Oncology. 17(9). S18–S18. 1 indexed citations

11.

Schöffski, Patrick, Maud Toulmonde, Anna Estival, et al.. (2021). Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG “ANITA”. European Journal of Cancer. 152. 26–40. 10 indexed citations

12.

Doménech, Marta, Andreas A. Argyriou, Noelia Vilariño, et al.. (2021). Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study. Annals of Translational Medicine. 9(8). 648–648. 5 indexed citations

13.

Doménech, Marta, Carlos Mesía, Anna Esteve, et al.. (2021). Long-term results of the GEINO 1401 TRIAL: Randomizing patients to stop or to continue temozolomide until 12 cycles.. Journal of Clinical Oncology. 39(15_suppl). 2013–2013. 1 indexed citations

14.

Pous, Anna, et al.. (2021). Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen. Translational Lung Cancer Research. 10(4). 1917–1923. 3 indexed citations

15.

Doménech, Marta, Ana M Muñoz‐Mármol, José Luís Mate, et al.. (2021). Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver. Oncotarget. 12(18). 1802–1810. 12 indexed citations

16.

Cucurull, Marc, et al.. (2020). Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution. Translational Lung Cancer Research. 9(1). 103–110. 14 indexed citations

17.

Estival, Anna, Carolina Sanz, José Luis Ramírez, et al.. (2019). Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients. Scientific Reports. 9(1). 11125–11125. 28 indexed citations

18.

García, Margarita, Rafael Moreno, Marta Gil-Martín, et al.. (2018). A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. Human Gene Therapy. 30(3). 352–364. 80 indexed citations

19.

Doménech, Marta, et al.. (2018). Successful treatment with brigatinib in a patient with ALK -rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease. Lung Cancer. 119. 99–102. 16 indexed citations

20.

García, Margarita, Rafael Moreno, Marta Gil, et al.. (2018). A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact